These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 28862987)

  • 21. Frequency and characterization of mutations in genes in a large cohort of patients referred to MODY registry.
    Breidbart E; Deng L; Lanzano P; Fan X; Guo J; Leibel RL; LeDuc CA; Chung WK
    J Pediatr Endocrinol Metab; 2021 May; 34(5):633-638. PubMed ID: 33852230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and laboratory clues of maturity-onset diabetes of the young and determination of association with molecular diagnosis.
    Karaoglan M; Nacarkahya G
    J Diabetes; 2021 Feb; 13(2):154-163. PubMed ID: 32710514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of Islet Autoantibodies and Modestly Raised Glucose Values at Diabetes Diagnosis Should Lead to Testing for MODY: Lessons From a 5-Year Pediatric Swedish National Cohort Study.
    Carlsson A; Shepherd M; Ellard S; Weedon M; Lernmark Å; Forsander G; Colclough K; Brahimi Q; Valtonen-Andre C; Ivarsson SA; Elding Larsson H; Samuelsson U; Örtqvist E; Groop L; Ludvigsson J; Marcus C; Hattersley AT
    Diabetes Care; 2020 Jan; 43(1):82-89. PubMed ID: 31704690
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted next generation sequencing in patients with maturity-onset diabetes of the young (MODY).
    Özdemir TR; Kırbıyık Ö; Dündar BN; Abacı A; Kaya ÖÖ; Çatlı G; Özyılmaz B; Acar S; Koç A; Güvenç MS; Kutbay YB; Erdoğan KM
    J Pediatr Endocrinol Metab; 2018 Dec; 31(12):1295-1304. PubMed ID: 30447144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Maturity onset diabetes of the young: identification and diagnosis.
    McDonald TJ; Ellard S
    Ann Clin Biochem; 2013 Sep; 50(Pt 5):403-15. PubMed ID: 23878349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus.
    Hohendorff J; Szopa M; Skupien J; Kapusta M; Zapala B; Platek T; Mrozinska S; Parpan T; Glodzik W; Ludwig-Galezowska A; Kiec-Wilk B; Klupa T; Malecki MT
    Endocrine; 2017 Aug; 57(2):272-279. PubMed ID: 28593615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maturity Onset Diabetes of the Young due to Glucokinase, HNF1-A, HNF1-B, and HNF4-A Mutations in a Cohort of Turkish Children Diagnosed as Type 1 Diabetes Mellitus.
    Ozsu E; Cizmecioglu FM; Yesiltepe Mutlu G; Yuksel AB; Calıskan M; Yesilyurt A; Hatun S
    Horm Res Paediatr; 2018; 90(4):257-265. PubMed ID: 30481753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spectrum of mutations in monogenic diabetes genes identified from high-throughput DNA sequencing of 6888 individuals.
    Bansal V; Gassenhuber J; Phillips T; Oliveira G; Harbaugh R; Villarasa N; Topol EJ; Seufferlein T; Boehm BO
    BMC Med; 2017 Dec; 15(1):213. PubMed ID: 29207974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia.
    Colclough K; Bellanne-Chantelot C; Saint-Martin C; Flanagan SE; Ellard S
    Hum Mutat; 2013 May; 34(5):669-85. PubMed ID: 23348805
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Systematic assessment of etiology in adults with a clinical diagnosis of young-onset type 2 diabetes is a successful strategy for identifying maturity-onset diabetes of the young.
    Thanabalasingham G; Pal A; Selwood MP; Dudley C; Fisher K; Bingley PJ; Ellard S; Farmer AJ; McCarthy MI; Owen KR
    Diabetes Care; 2012 Jun; 35(6):1206-12. PubMed ID: 22432108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low genetic confirmation rate in South Indian subjects with a clinical diagnosis of maturity-onset diabetes of the young (MODY) who underwent targeted next-generation sequencing for 13 genes.
    Sampathkumar G; Valiyaparambil PP; Kumar H; Bhavani N; Nair V; Menon U; Menon A; Abraham N; Chapla A; Thomas N
    J Endocrinol Invest; 2022 Mar; 45(3):607-615. PubMed ID: 34741762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. De novo mutations of GCK, HNF1A and HNF4A may be more frequent in MODY than previously assumed.
    Stanik J; Dusatkova P; Cinek O; Valentinova L; Huckova M; Skopkova M; Dusatkova L; Stanikova D; Pura M; Klimes I; Lebl J; Gasperikova D; Pruhova S
    Diabetologia; 2014 Mar; 57(3):480-4. PubMed ID: 24323243
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of young patients with HNF1A mutations (HNF1A-MODY).
    Raile K; Schober E; Konrad K; Thon A; Grulich-Henn J; Meissner T; Wölfle J; Scheuing N; Holl RW;
    Diabet Med; 2015 Apr; 32(4):526-30. PubMed ID: 25483937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic characterization of suspected MODY patients in Tunisia by targeted next-generation sequencing.
    Dallali H; Pezzilli S; Hechmi M; Sallem OK; Elouej S; Jmel H; Ben Halima Y; Chargui M; Gharbi M; Mercuri L; Alberico F; Mazza T; Bahlous A; Ben Ahmed M; Jamoussi H; Abid A; Trischitta V; Abdelhak S; Prudente S; Kefi R
    Acta Diabetol; 2019 May; 56(5):515-523. PubMed ID: 30656436
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic Confirmation Rate in Clinically Suspected Maturity-Onset Diabetes of the Young.
    Brahm AJ; Wang G; Wang J; McIntyre AD; Cao H; Ban MR; Hegele RA
    Can J Diabetes; 2016 Dec; 40(6):555-560. PubMed ID: 27634015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Comprehensive Analysis of Hungarian MODY Patients-Part I: Gene Panel Sequencing Reveals Pathogenic Mutations in
    Gaál Z; Szűcs Z; Kántor I; Luczay A; Tóth-Heyn P; Benn O; Felszeghy E; Karádi Z; Madar L; Balogh I
    Life (Basel); 2021 Jul; 11(8):. PubMed ID: 34440499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HNF1A gene p.I27L is associated with early-onset, maturity-onset diabetes of the young-like diabetes in Turkey.
    Beysel S; Eyerci N; Pinarli FA; Kizilgul M; Ozcelik O; Caliskan M; Cakal E
    BMC Endocr Disord; 2019 May; 19(1):51. PubMed ID: 31109344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes.
    McDonald TJ; Shields BM; Lawry J; Owen KR; Gloyn AL; Ellard S; Hattersley AT
    Diabetes Care; 2011 Aug; 34(8):1860-2. PubMed ID: 21700917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maturity onset diabetes of the young in India - a distinctive mutation pattern identified through targeted next-generation sequencing.
    Chapla A; Mruthyunjaya MD; Asha HS; Varghese D; Varshney M; Vasan SK; Venkatesan P; Nair V; Mathai S; Paul TV; Thomas N
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):533-42. PubMed ID: 25041077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary C-peptide creatinine ratio is a practical outpatient tool for identifying hepatocyte nuclear factor 1-{alpha}/hepatocyte nuclear factor 4-{alpha} maturity-onset diabetes of the young from long-duration type 1 diabetes.
    Besser RE; Shepherd MH; McDonald TJ; Shields BM; Knight BA; Ellard S; Hattersley AT
    Diabetes Care; 2011 Feb; 34(2):286-91. PubMed ID: 21270186
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.